HomeCGEM • NASDAQ
add
Cullinan Therapeutics Inc
Previous close
$11.13
Day range
$10.50 - $11.26
Year range
$10.00 - $30.19
Market cap
651.57M USD
Avg Volume
531.91K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 48.86M | 9.04% |
Net income | -40.56M | -3.51% |
Net profit margin | — | — |
Earnings per share | -0.69 | 23.93% |
EBITDA | -48.78M | -9.07% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 578.08M | 23.94% |
Total assets | 653.25M | 32.05% |
Total liabilities | 25.39M | -1.92% |
Total equity | 627.86M | — |
Shares outstanding | 58.23M | — |
Price to book | 1.03 | — |
Return on assets | -18.30% | — |
Return on capital | -18.95% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -40.56M | -3.51% |
Cash from operations | -34.14M | 0.01% |
Cash from investing | 19.88M | 146.27% |
Cash from financing | 1.32M | 1,083.04% |
Net change in cash | -12.94M | 83.20% |
Free cash flow | -19.00M | 5.90% |
About
Founded
2016
Website
Employees
85
